# Clinical and Translational Science Award

> **NIH NIH UL1** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2020 · $9,364,151

## Abstract

Contact PD/PI: GINSBERG, HENRY N
OVERALL ABSTRACT
Our CTSA Hub is situated in the Irving Institute for Clinical and Translational Research (Irving Institute) of
Columbia University (CU), and based at the CU Medical Center (CUMC) in Northern Manhattan (NM). The CU
College of Physicians and Surgeons (P&S), Mailman School of Public Health (MSPH), College of Dental
Medicine (CDM), and School of Nursing (SON) are all at CUMC together with major components of New York
Presbyterian Hospital (NYP) and the New York State Psychiatric Institute (NYSPI). The vision of the Irving
Institute is: 1) to transform the culture of biomedical research enabling CUMC investigators to develop new
treatments faster and deliver those treatments to patients more efficiently, effectively, and safely than ever
before; 2) to utilize medical research advances to benefit patients and the community, converting knowledge
into practice; and 3) to recruit, train, support and nurture the next generation of clinical and translational
investigators in multi- and interdisciplinary team science environments. Since first receiving CTSA funding in
2006, we embraced a vision that would impact maximally on a) individuals, particularly junior faculty and
trainees, b) groups of faculty and trainees working in common areas of interest but often in relative isolation,
and 3) the institutional culture. We believed that this bottom-up approach was necessary if we were to move
CUMC from a system that rewarded individual effort more than the achievements of groups. After nine years,
we are certain that we have changed the environment significantly, and that CUMC and NYP both understand
that multidisciplinary team efforts are essential for success in this era of greater complexity both in science and
in clinical care. Additionally, we all have come to understand that only by engaging our patients early in the
research process, particularly those individuals in the communities of Northern Manhattan (NM), will we gain
their trust and enthusiasm, two keys to their participation in the revolution generated by Precision Medicine.
Our aim is to expand, enhance, and improve the Irving Institute's CTSA Hub, to ensure that we create an
outstanding environment where junior and senior faculty, trainees, clinical research coordinators, nurses,
support staff, and patients, particularly members of the underserved and underrepresent communities of NM
are all engaged in, and benefit from, our efforts to meet the exciting and unique opportunities afforded by the
CU/NYP Precision Medicine Initiative and the extraordinary advancements in information technologies, `omics',
and therapeutic possibilities. Innovations and achievements at our Hub will be disseminated for the benefit of
our local neighboring Hubs and the CTSA Hub Network.
Project Summary/Abstract Page 162
Contact PD/PI: GINSBERG, HENRY N
Narrative
The Clinical and Translational Science Award (CTSA) allows Columbia University to support novel programs
whose ...

## Key facts

- **NIH application ID:** 9938711
- **Project number:** 5UL1TR001873-05
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Muredach P Reilly
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $9,364,151
- **Award type:** 5
- **Project period:** 2016-07-01 → 2021-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9938711

## Citation

> US National Institutes of Health, RePORTER application 9938711, Clinical and Translational Science Award (5UL1TR001873-05). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/9938711. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*